Nightmare stories of nurses giving potent drugs meant for one patient to another and surgeons removing the wrong body parts have dominated recent headlines about medical care. Lest you assume those cases are the exceptions, a new study by patient-safety researchers provides some context.

Insurers will seek significant premium hikes under President Barack Obama’s health care law this summer — stiff medicine for consumers and voters ahead of the national political conventions.

There are few things as flat out baffling as a medical bill.

Health insurers and patients could safely save many billions of dollars annually by swapping out a more expensive drug for a less expensive generic in the same class of drugs, according to a study published Monday.

As proposed health insurance premium rates for 2017 are being filed with state insurance departments across the country, actuaries are providing an early look at what’s driving changes in premium rates for 2017 within the Affordable Care Act (ACA) individual and small group markets. A new issue brief produced by the American Academy of Actuaries’ Individual and Small Group Markets Committee, “Drivers of 2017 Health Insurance Premium Changes,” outlines the drivers.

If patients know how much their medical care costs, they’ll shop around for the cheapest option — and over time, health care costs will go down. At least, that’s the idea behind the drive to improve price transparency, a strategy embraced by Donald Trump, among others.